Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-050308
Filing Date
2010-05-17
Accepted
2010-05-17 15:13:22
Documents
12
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g23297e10vq.htm 10-Q 153305
2 EX-4.6.1 g23297exv4w6w1.htm EX-4.6.1 18410
3 EX-4.6.2 g23297exv4w6w2.htm EX-4.6.2 21001
4 EX-4.7 g23297exv4w7.htm EX-4.7 20802
5 EX-10.9.4 g23297exv10w9w4.htm EX-10.9.4 7117
6 EX-10.19 g23297exv10w19.htm EX-10.19 54427
7 EX-10.21.2 g23297exv10w21w2.htm EX-10.21.2 31087
8 EX-31.1 g23297exv31w1.htm EX-31.1 7554
9 EX-31.2 g23297exv31w2.htm EX-31.2 7861
10 EX-32.1 g23297exv32w1.htm EX-32.1 4209
11 GRAPHIC g23297g2329700.gif GRAPHIC 6593
12 GRAPHIC g23297g2329701.gif GRAPHIC 213275
  Complete submission text file 0000950123-10-050308.txt   630393
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 10838045
SIC: 2834 Pharmaceutical Preparations